Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis

被引:0
|
作者
Hawkins, P.N. [1 ]
Aprile, C. [2 ,5 ]
Capri, G. [3 ]
Vigano, L. [3 ]
Munzone, E. [3 ]
Gianni, L. [3 ]
Pepys, M.B. [1 ]
Merlini, G. [4 ]
机构
[1] Immunological Medicine Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom
[2] Nuclear Medicine Service, Scientific Institute Fondazione Maugeri, Pavia, Italy
[3] Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy
[4] Biotechnology Research Laboratories, University Hospital S. Matteo, Pavia, Italy
[5] Fond. S.Maugeri- Nuclear Med. Serv., 8,v.Ferrata, I- 27100 Pavia, Italy
关键词
D O I
暂无
中图分类号
学科分类号
摘要
19
引用
收藏
页码:701 / 708
相关论文
共 50 条
  • [41] Role of dual modality I123 serum amyloid P component SPECT-CT imaging in amyloidosis
    Hutt, D. F.
    Lane, T.
    Gillmore, J. D.
    Lachmann, H. J.
    Gibbs, S. D. J.
    Sattianayagam, P. T.
    Gopaul, D.
    Quigley, A. M.
    Hawkins, P. N.
    Wechalekar, A. D.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 57 - 57
  • [42] Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis
    Hazenberg, Bouke P. C.
    van Rijswijk, Martin H.
    Lub-de Hooge, Marjolijn N.
    Vellenga, Edo
    Haagsma, Elizabeth B.
    Posthumus, Marcel D.
    Jager, Pieter L.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (06) : 865 - 872
  • [43] Echocardiographic assessment of cardiac involvement in systemic AL amyloidosis in relation to whole body amyloid load measured by serum amyloid P component (SAP) clearance
    Clesham, GJ
    Vigushin, DM
    Hawkins, PN
    Pepys, MB
    Oakley, CM
    Nihoyannopoulos, P
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (08): : 1104 - &
  • [44] Serum amyloid P component (SAP) concentration in abdominal fat aspirates of patients with amyloidosis
    Bijzet, J.
    Hazenberg, B. P. C.
    Hawkins, P. N.
    Leijsma, M. K.
    Brouwer, E.
    Posthumus, M. D.
    Van Rijswijk, M. H.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2006, 13 : 19 - 19
  • [45] Serum amyloid P component: Normal functions and role in pathogenesis, diagnosis and treatment of amyloidosis
    Pepys, MB
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 : 23 - 26
  • [46] SERUM AMYLOID P COMPONENT - A PREDICTOR OF CLINICAL BETA-2-MICROGLOBULIN AMYLOIDOSIS
    SPIEGEL, DM
    SPRAGUE, SM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (05) : 427 - 432
  • [47] Serum amyloid P component (SAP) concentration in abdominal fat aspirates of patients with amyloidosis
    Bijzet, J.
    Hazenberg, B. P. C.
    Hawkins, P. N.
    Leijsma, M. K.
    Brouwer, E.
    Posthumus, M. D.
    van Rijswijk, M. H.
    XIth International Symposium on Amyloidosis, 2008, : 350 - 351
  • [48] Visual assessment of scintigraphy at different time intervals after administration of 123I labelled serum amyloid P component (SAP) in patients with amyloidosis
    Hazenberg, BPC
    Jager, PL
    Piers, D
    Limburg, PC
    De Hooge, MN
    Van Rijswijk, MH
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 337 - 338
  • [49] Scintigraphy using iodine 123-labeled serum amyloid P component in ten patients with secondary AA type amyloidosis - A descriptive study
    Feutrie, ML
    Hachulla, E
    Flipo, RM
    Huglo, D
    Maulin, L
    Deveaux, M
    Duquesnoy, B
    Delcambre, B
    Marchandise, X
    REVUE DU RHUMATISME, 1996, 63 (11): : 866 - 869
  • [50] Studies of serum amyloid P component (SAP) and antinuclear autoimmunity.
    Gillmore, JD
    Hutchinson, WL
    Mitchell, DA
    Herbert, J
    Botto, M
    Walport, MJ
    Pepys, MB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 167A - 168A